|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61P 35/00 |
| (11) | Patento numeris | 2340837 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11155582.7 |
| Europos patento paraiškos padavimo data | 2006-11-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 05110669 | 2005-11-11 | EP |
| (72) |
Solca, Flavio, AT
Amelsberg, Andree, US
Van Meel, Jacobus C.A., AT
Baum, Anke, AT
Stehle, Gerd, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim am Rhein, DE |
| (54) | COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS |
| COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS |